Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The inferolateral genicular nerve is a peripheral sensory nerve branch that provides innervation to the knee joint. It typically arises from the common peroneal nerve (common fibular nerve) and travels across the lateral head of the gastrocnemius muscle to reach the lateral and inferior aspects of the knee capsule. In clinical practice, it is primarily regarded as an anatomical target for interventional pain management rather than a molecular or pharmacological target. Procedures such as genicular nerve blocks or radiofrequency ablation (RFA) are frequently employed to treat chronic knee pain associated with osteoarthritis or failed total knee arthroplasty. While not a molecule or receptor, it is the focus of therapies using local anesthetics and neurolytic agents to interrupt pain signaling from the joint to the central nervous system.
Inhibition of sodium channels to block axonal conduction (local anesthetics); modulation of inflammatory response (corticosteroids); chemical neurolysis (phenol).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inferolateral genicular nerve (ILGN).